| Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease |
10 |
| May Measurement Month 2017 blood pressure screening: findings from Malaysia-South-East Asia and Australasia |
9 |
| Pharmacological properties of betrixaban |
8 |
| Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate |
7 |
| Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together |
6 |
| Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments |
6 |
| Hyperkalaemia: aetiology, epidemiology, and clinical significance |
5 |
| Current treatment and unmet needs of hyperkalaemia in the emergency department |
5 |
| May Measurement Month 2017: an analysis of blood pressure screening results in China-East Asia |
5 |
| Immediate and late impact of reperfusion therapies in acute pulmonary embolism |
5 |
| The burden of comorbidities in pulmonary arterial hypertension |
5 |
| Screening strategies for pulmonary arterial hypertension |
5 |
| May Measurement Month 2017: an analysis of the blood pressure screening campaign results in Indonesia-South-East Asia and Australasia |
4 |
| Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe |
4 |
| May Measurement Month 2017: an analysis of blood pressure screening in Sudan-Northern Africa and Middle East |
4 |
| Catheter-directed therapy for acute pulmonary embolism: navigating gaps in the evidence |
4 |
| Future biomarkers in cardiology: my favourites |
4 |
| How to improve therapy in myocarditis: role of cardiovascular magnetic resonance and of endomyocardial biopsy |
4 |
| Landiolol for managing post-operative atrial fibrillation |
4 |
| Ageing, demographics, and heart failure |
4 |
| Percutaneous treatment of tricuspid valve in refractory right heart failure |
3 |
| Cardiac cachexia |
3 |
| Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia |
3 |
| New frontiers for management of hyperkalaemia: the emergence of novel agents |
3 |
| May Measurement Month 2017: Results of 39 national blood pressure screening programmes |
3 |
| Renal function, electrolytes, and congestion monitoring in heart failure |
3 |
| Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease |
3 |
| The revised definition of pulmonary hypertension: exploring the impact on patient management |
3 |
| Update on high-sensitivity cardiac troponin in patients with suspected myocardial infarction |
3 |
| The past, the present, and the future of natriuretic peptides in the diagnosis of heart failure |
3 |
| May Measurement Month 2017: screening for hypertension in Nigeria-Sub-Saharan Africa |
3 |
| Implantable devices for heart failure monitoring: the CardioMEMS (TM) system |
2 |
| Remote monitoring and telemedicine |
2 |
| Monitoring the heart during cancer therapy |
2 |
| MMM17-Cameroon, analysis and opportunities Sub-Saharan Africa |
2 |
| May Measurement Month 2017: analysis of the blood pressure screening results in Ecuador-Americas |
2 |
| Rates of untreated, treated, and controlled hypertension and relationships between blood pressure with other cardiovascular risk factors in Brazzaville (Republic of the Congo): May Measurement Month 2017-Sub-Saharan Africa |
2 |
| May Measurement Month 2017: an analysis of the blood pressure screening campaign results in India-South Asia |
2 |
| May Measurement Month 2017: an analysis of blood pressure screening results in South Africa- Sub-Saharan Africa |
2 |
| Do we know more about hypertension in Poland after the May Measurement Month 2017?- Europe |
2 |
| May Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland-Europe |
2 |
| Blood pressure screening during the May Measurement Month 2017 programme in Vietnam-South-East Asia and Australasia |
2 |
| May Measurement Month 2017: Results from Taiwan-East Asia |
2 |
| May Measurement Month 2017: Blood pressure screening results from Zambia-Sub-Saharan Africa |
2 |
| Rationale for catheter-based therapies in acute pulmonary embolism |
2 |
| Monitoring of iron status in patients with heart failure |
2 |
| Landiolol for managing atrial fibrillation in post-cardiac surgery |
2 |
| Epicardial ablation in genetic cardiomyopathies: a new frontier |
2 |
| The complex interplay between fitness, genetics, lifestyle, and inflammation in the pathogenesis of coronary atherosclerosis: lessons from the Amazon rainforest |
2 |
| Frailty in patients with heart failure |
2 |
